Prime Medicine, Inc. Common Stock (PRME) valuation · rev $4.6M
Prime Medicine, Inc. Common Stock (PRME) rev $4.6M.
| Metric | Value |
|---|---|
| Market cap | $570.8M |
| Revenue | $4.6M |
| P/S | 123.2 |
| P/B | 7.4 |
PRME valuation FAQ
What is PRME's market cap?
Prime Medicine, Inc. Common Stock (PRME) market cap is $570.8M on the latest cached fundamentals snapshot.
What is PRME's latest revenue?
Latest cached Prime Medicine, Inc. Common Stock (PRME) revenue was $4.6M. Statements: https://lician.com/financials/prme
What is PRME's price-to-sales ratio?
Prime Medicine, Inc. Common Stock (PRME) price-to-sales (P/S) is 123.2, cached market cap $570.8M divided by revenue $4.6M.
What is PRME's price-to-book ratio?
Prime Medicine, Inc. Common Stock (PRME) price-to-book (P/B) is 7.4 on the latest cached fundamentals snapshot.
How many PRME valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for Prime Medicine, Inc. Common Stock (PRME): Market cap, Revenue, P/S, and P/B.
Where is PRME valuation listed?
Cached valuation multiples for Prime Medicine, Inc. Common Stock (PRME) are listed at https://lician.com/valuation/prme.
Not investment advice. Cached rows, not a live tape.